Literature DB >> 928268

The demonstration of atenolol as a beta-adrenoceptor blocking drug in man.

J D Harry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 928268

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  7 in total

1.  Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.

Authors:  J M Rapola; T J Pellinen; P Koskinen; L Toivonen; M S Nieminen
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

2.  Haemodynamic effects of atenolol in patients with coronary artery disease.

Authors:  C Robinson; G Jackson; C Fisk; D Jewitt
Journal:  Br Heart J       Date:  1978-01

Review 3.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

4.  Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.

Authors:  G Jackson; J D Harry; C Robinson; D Kitson; D E Jewitt
Journal:  Br Heart J       Date:  1978-09

5.  Experience with a Doppler technique to investigate the interaction of isoprenaline and various B-adrenoceptor blocking drugs on blood vessels in the lower limb.

Authors:  D E FitzGerald; J D Harry
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.

Authors:  W Reid; D J Ewing; J D Harry; H J Smith; J M Neilson; B F Clarke
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

7.  Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.

Authors:  G Leopold; W Ungethüm; J Pabst; Z Simane; K U Bühring; H Wiemann
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.